Clinical trial
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C…
NCT00375895 · Rennes University Hospital, Other · Terminated
Key facts
| NCT number | NCT00375895 |
|---|---|
| Title | Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation |
| Official title | Prospective, Open-label, Single Arm Pilot Study Evaluating the Effect on Virological Response of the Switch From Tacrolimus to Cyclosporin Associated With a Peginterferon Alfa-2a / Ribavirin Bitherapy, in Non-responder or With Recurrent VHC+ Disease Liver Transplanted Patients. |
| Lead sponsor | Rennes University Hospital, Other |
| Collaborators | Novartis Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, Evidence of Liver Transplantation |
| Intervention type | Drug |
| Interventions | ciclosporin |
| Enrollment | 11 |
| Start date | Jun 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Sep 13, 2006 |
| Last update posted | Mar 2, 2012 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: